ENHANCING THE RESPONSIVENESS OF GLIOMAS TO IMMUNOTHERAPY BY PHARMACOLOGICAL INHIBITION OF CHEK2: SETTING THE STAGE FOR A CLINICAL TRIAL
$237,000FY2020Defense Health AgencyDOD
Northwestern University, Evanston IL
Investigators
View source on USAspending →ENHANCING THE RESPONSIVENESS OF GLIOMAS TO IMMUNOTHERAPY BY PHARMACOLOGICAL INHIBITION OF CHEK2: SETTING THE STAGE FOR A CLINICAL TRIAL · GrantIndex